Related Experiment Video
Updated: May 17, 2026
11:48
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Aberrant alternative splicing events in Parkinson's disease
Ru-Huei Fu1, Shih-Ping Liu, Shyh-Jer Huang
1Center for Neuropsychiatry, China Medical University Hospital, Taichung, Taiwan, ROC.
Cell Transplantation
|November 7, 2012
Summary
Aberrant alternative splicing (AS) in Parkinson's disease (PD) involves six key genes. AS profiles may offer new diagnostic, prognostic, and therapeutic strategies for this neurodegenerative disorder.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- Alternative splicing (AS) generates transcript diversity, impacting nervous system function and development.
- Aberrant AS is implicated in neurodegenerative diseases, including Parkinson's disease (PD).
- PD is characterized by protein aggregation and dopaminergic neuron loss, affecting millions globally.
Purpose of the Study:
- To review the significance of aberrant alternative splicing (AS) in Parkinson's disease (PD).
- To explore the potential of AS profiles as diagnostic or prognostic markers for PD.
- To discuss AS-targeted therapeutic strategies for PD.
Main Methods:
- Literature review focusing on AS events in PD.
- Identification of genes associated with aberrant AS in PD patients.
- Analysis of the role of AS in PD pathogenesis.
Main Results:
- Six genes (PARK2, SNCAIP, LRRK2, SNCA, SRRM2, MAPT) are linked to aberrant AS in PD.
- AS plays critical roles in nervous system functions like neurotransmission and memory.
- Aberrant AS contributes to PD pathology.
Conclusions:
- Aberrant AS is a relevant factor in Parkinson's disease.
- AS profiles show promise as potential biomarkers for PD diagnosis and prognosis.
- Targeting aberrant AS could represent a novel therapeutic avenue for PD.
Related Concept Videos
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...